The global metagenomics sequencing market size was US$ 1139.3 million in 2021. The global metagenomics sequencing market is forecast to grow to US$ 3,994.01 million by 2030 by registering a compound ...

With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...

Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density microarray patch (HD-MAP) for clinical studies at a biomedical facility in ...

Vaxxas Chair Sarah Meibusch said, "The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress toward commercialising our HD-MAP technology. By reducing cold-chain ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...

A recent study on DNA microarray technology highlights its essential role in enabling high-throughput analysis of large numbers of genes through arrays of probes integrated on a solid-phase support.

As genetic analysis expands to serve everything from population-scale studies to precision-driven clinical decisions, laboratories are under growing pressure to move faster while managing increasingly ...

InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary ...